Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Burdick

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Structure-based design of thienobenzoxepin inhibitors of PI3-kinaseSteven T Staben, Michael Siu, Richard Goldsmith, et al.
Biochemistry|January 5, 2022
A Multifaceted Hit-Finding Approach Reveals Novel LC3 Family LigandsMicah Steffek, Elizabeth Helgason, Nataliya Popovych, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutationEmily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
Science (New York, N.Y.)|February 9, 2002
Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small moleculeT R Gadek, D J Burdick, R S McDowell, et al.
Transplantation|September 15, 1996
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study GroupE S Woodle, J R Thistlethwaite, J H Gordon, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 InhibitorBryan K Chan, Anthony A Estrada, Huifen Chen, et al.
Science Translational Medicine|December 18, 2012
Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutationsZejuan Sheng, Shuo Zhang, Daisy Bustos, et al.
JAMA|February 24, 2001
Consensus statement on the live organ donorM Abecassis, M Adams, P Adams, et al.
Journal of Medicinal Chemistry|October 6, 2018
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-likeShumei Wang, Vickie Tsui, Terry D Crawford, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2)Terry D Crawford, James E Audia, Steve Bellon, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Structure-based design of thienobenzoxepin inhibitors of PI3-kinaseSteven T Staben, Michael Siu, Richard Goldsmith, et al.
Biochemistry|January 5, 2022
A Multifaceted Hit-Finding Approach Reveals Novel LC3 Family LigandsMicah Steffek, Elizabeth Helgason, Nataliya Popovych, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutationEmily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
Science (New York, N.Y.)|February 9, 2002
Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small moleculeT R Gadek, D J Burdick, R S McDowell, et al.
Transplantation|September 15, 1996
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study GroupE S Woodle, J R Thistlethwaite, J H Gordon, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 InhibitorBryan K Chan, Anthony A Estrada, Huifen Chen, et al.
Science Translational Medicine|December 18, 2012
Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutationsZejuan Sheng, Shuo Zhang, Daisy Bustos, et al.
JAMA|February 24, 2001
Consensus statement on the live organ donorM Abecassis, M Adams, P Adams, et al.
Journal of Medicinal Chemistry|October 6, 2018
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-likeShumei Wang, Vickie Tsui, Terry D Crawford, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2)Terry D Crawford, James E Audia, Steve Bellon, et al.
Pageof 13